Protein Potential

Protein Potential is a clinical-stage biotechnology company dedicated to developing vaccines against major global infectious diseases, with a primary focus on enteric pathogens and malaria. Based in Rockville, Maryland, the company leverages its expertise in recombinant protein expression and purification to create complex, multi-antigen vaccine candidates. Its lead programs include a quadrivalent Shigella vaccine and various malaria vaccine components developed in collaboration with its sister company, Sanaria. Protein Potential's approach combines advanced molecular biology with scalable manufacturing processes to address unmet needs in both tropical medicine and traveler's health. The company has secured significant funding through federal grants and international partnerships to advance its diverse pipeline through clinical proof-of-concept.